Clinical trial
Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma
NCT00430261 · Swedish Medical Center, Other · Completed
Key facts
| NCT number | NCT00430261 |
|---|---|
| Title | Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma |
| Official title | Phase II Trial of Sunitinib in Bronchoalveolar Carcinoma or Never-Smokers With Any Lung Adenocarcinoma |
| Lead sponsor | Swedish Medical Center, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Adenocarcinoma |
| Intervention type | Drug |
| Interventions | sunitinib |
| Enrollment | 20 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Feb 1, 2007 |
| Last update posted | Oct 6, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: